Search Results
Nov 10, 2025, 16:47 ET Calliditas Therapeutics Reports Safety Data for Setanaxib in Patients with Alport Syndrome at the American Society of Nephrology Kidney Week
Alport syndrome is a rare genetic kidney disease resulting from mutations in collagen type IV genes that can lead to progressive loss of kidney function and end-stage kidney
More news about: Calliditas Therapeutics
Nov 10, 2025, 16:05 ET Federal Realty Appoints Joseph D. Fisher to Board of Trustees
homes across major U.S. markets. "Joe's track record as both an operator and a strategic leader in the REIT industry gives him a rare perspective on how to create lasting value," said Donald C. Wood, Chief Executive Officer of Federal Realty. "He brings deep experience in real estate
More news about: Federal Realty Investment Trust
Nov 10, 2025, 16:05 ET Avidity Biosciences Reports Third Quarter 2025 Financial Results and Recent Highlights
into muscle and is leading the field with clinical development programs for three rare muscle diseases: DM1, DMD and FSHD. Avidity is also advancing two wholly-owned precision cardiology development candidates addressing rare genetic cardiomyopathies. In addition, Avidity is broadening the reach of AOCs
More news about: Avidity Biosciences, Inc.
Nov 10, 2025, 16:05 ET Theravance Biopharma, Inc. Reports Third Quarter 2025 Financial Results and Provides Corporate Update
available therapies, many MSA patients remain symptomatic with nOH.11 Neurogenic orthostatic hypotension (nOH) is a rare disorder defined as a fall in systolic blood pressure of ⩾20 mm Hg or diastolic blood pressure of ⩾10 mm Hg, within 3 minutes of standing. Severely
More news about: Theravance Biopharma, Inc.
Nov 10, 2025, 16:00 ET Under the Moonlight: Luna Launch Event Marks Start of Pre-Construction Sales for Tampa Bay's Next Luxury Waterfront Tower
from 1,100 to over 3,500 square feet, priced from $1 million to over $4 million. These new pre-construction luxury condos in Tampa Bay offer buyers a rare opportunity to invest early in one of the region's most coveted waterfront communities, where Tower I is already sold out. Located
More news about: Marina Pointe
Nov 10, 2025, 14:45 ET INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation of Soleno Therapeutics, Inc. (NASDAQ: SLNO) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm
COMPANY: Soleno Therapeutics is a biopharmaceutical company dedicated to creating innovative treatments for rare diseases. THE ALLEGED WRONGDOING:
More news about: Edelson Lechtzin LLP
Nov 10, 2025, 12:15 ET Illumina® Protein Prep delivers groundbreaking precision in NGS proteomics for more than 40 customers, ranging from academic institutions to large national biobanks
clinical mass spectrometry studies with Illumina Protein Prep. Genomics England expanded study advances rare disease research As an early-access customer, Genomics England used Illumina Protein Prep as part of a
More news about: Illumina, Inc.
Nov 10, 2025, 11:30 ET Lehigh Valley Transforms into a Holiday Wonderland with Beloved Traditions and Enchanting Experiences for 2025
holidays; we're peeling back the curtain and offering them the experience of true holiday magic. In a world where genuine experiences are increasingly rare, Lehigh Valley offers something money can't buy: genuine holiday spirit." Festive Favorites Return for 2025
More news about: Discover Lehigh Valley
Nov 10, 2025, 11:05 ET ZAC Cognitive Explainable-AI for Situational Awareness recognized as far superior algorithm to achieve Self-Driving Level-5 than Neural Nets
ZAC can understand unexpected/rare situations/events, a pre-requisite for Situational Awareness for Level-5 Self-Driving "Investors Hangout"
More news about: Z Advanced Computing, Inc.
Nov 10, 2025, 10:35 ET Stranahan's Snowflake Redcloud Peak Crowned Best American Single Malt Whiskey at the 2025 San Francisco World Spirits Competition
Snowflake is an annual winter release by Stranahan's that showcases an array of rare and worldly cask finishes harmonized in one bottle of American single malt. Since its initial release in 2011, Snowflake has earned global attention
More news about: Stranahan's American Single Malt Whiskey
Nov 10, 2025, 10:00 ET US STRATEGIC METALS INKS MOU WITH IONIC RARE EARTHS LIMITED FOR MISSOURI MAGNET RECYCLING
IonicRE to provide Ionic Technologies' patented rare earth permanent magnet recycling technology, focused on rapid production of magnet rare earth oxides (REOs), with future potential expansion to include a range of magnet and heavy rare earths from mixed rare earth carbonate (MREC); and
More news about: US Strategic Metals
Nov 10, 2025, 10:00 ET Geneseeq Receives NMPA Approval for PanTRKare™ - China's First NGS-Based Pan-Solid Tumor Companion Diagnostic Kit for NTRK Gene Fusions
Addressing Unmet Clinical Needs: Shedding Light on Rare Mutations NTRK gene family fusions occur in less than 1% of all solid tumors, but represent one of the most
More news about: Geneseeq Technology Inc.
Nov 10, 2025, 09:17 ET Yesway Appoints Robert "Robbie" Drake as Vice President of Facilities
accountability, improve cost control, and streamline processes for both in-house and third-party maintenance activities. "Robbie brings a rare blend of strategic vision and hands-on technical expertise to our organization," said Thomas W. Brown, Chief Real Estate Officer at Yesway. "His track
More news about: Yesway
Nov 10, 2025, 09:15 ET TriNet Unveils 2025 State of the Workplace Report
employee indifference dropping from 31% to 19%. Childcare assistance emerges as a rare point of employer-employee alignment, as both sides show rising support—employers boosting "extremely important" and "somewhat important" ratings
More news about: TriNet
Nov 10, 2025, 09:00 ET AlphaSense Names Nilka Thomas as Chief People Officer
she held senior HR and talent leadership roles focused on global staffing, culture, and inclusion initiatives. "Nilka brings a rare combination of strategic vision, empathy, and hands-on experience leading global people organizations through high growth and scale," said Jack Kokko,
More news about: AlphaSense
Nov 10, 2025, 09:00 ET Saks Fifth Avenue and Neiman Marcus Host the Third Annual Bejeweled Ball, Celebrating the World's Most Remarkable High Jewelry and Timepieces
came together to celebrate the world's most prestigious jewelry maisons. Across the experience, guests discovered a dazzling array of fine jewelry, rare timepieces and one-of-a-kind styles, to both view and collect in an intimate, immersive setting. The gala brought to life the revered Bejeweled Ball
More news about: Saks Global
Nov 10, 2025, 09:00 ET NEURELIS TO PARTICIPATE IN SOFIE'S JOURNEY EPILEPSY AWARENESS DAY AND EDUCATION EXPO AT DISNEYLAND® RESORT
BA-1049), an investigational, Phase 1 new chemical entity Rho kinase (ROCK) inhibitor, for the treatment of cerebral cavernous malformations (CCMS), a rare disorder of the central nervous system (CNS). For more information on Neurelis, please visit
More news about: Neurelis, Inc.
Nov 10, 2025, 08:46 ET Novo Nordisk's Wegovy® (semaglutide 2.4 mg) was associated with liver health-related benefits not solely based on weight loss in adult patients with MASH with liver scarring, according to a new post hoc analysis
years in diabetes care. Building on this foundation, our purpose is to drive change to defeat serious chronic diseases — from diabetes and obesity to rare blood and endocrine disorders — by pioneering scientific breakthroughs, expanding access to medicines, and working to prevent and ultimately cure disease.
More news about: NOVO NORDISK INC.
Nov 10, 2025, 08:45 ET Novo Nordisk's Wegovy® (semaglutide 2.4 mg) was associated with liver health-related benefits not solely based on weight loss in adult patients with MASH with liver scarring, according to a new post hoc analysis
years in diabetes care. Building on this foundation, our purpose is to drive change to defeat serious chronic diseases — from diabetes and obesity to rare blood and endocrine disorders — by pioneering scientific breakthroughs, expanding access to medicines, and working to prevent and ultimately cure disease.
More news about: NOVO NORDISK INC.
Nov 10, 2025, 08:42 ET Morphy's Oct. 4-5 Auction of Prized Automobilia and Petroliana Raced to a $1.7M Finish
name LITTLE BEAR GASOLINE in contrasting white letters. It roared at $13,530 against an estimate of $5,000-$10,000. A rare and stunning 15-inch single-globe lens boldly advertised the message "Tiger Gasoline" with an artful tiger graphic and unique script style. Very little
More news about: Morphy Auctions
Nov 10, 2025, 08:34 ET BidItUp, Fram Fram, and Corporate Assets Announce Private Treaty Sale of Complete Dexter Stamping Facility in Tennessee -- Over $50 Million in New Equipment Cost
premier automotive manufacturing operation located in Tennessee. Representing more than $50,000,000 in new equipment cost, this offering presents a rare opportunity to acquire a fully equipped, late-model, turnkey stamping and wire-forming facility with a proven legacy of performance and precision.
More news about: BidItUp Auctions Worldwide
Nov 10, 2025, 08:00 ET Tiumbio to Present First Clinical Data for Dual TGF-β/VEGF Inhibitor Tosposertib (TU2218) at SITC 2025, "Robust Response Rate"
(SITC) 2025 annual meeting, Tiumbio Co., Ltd. (KOSDAQ: 321550), a clinical-stage biopharmaceutical company dedicated to developing novel therapies for rare and intractable diseases, today shared the interim Phase II clinical data for its "first-in-class" Tosposertib (TU2218), a dual inhibitor against TGFβ
More news about: TiumBio
Nov 10, 2025, 07:00 ET LISCure Biosciences Initiates Global Phase 2 Trial of LB-P8 in Primary Sclerosing Cholangitis (PSC)
patient dosing in a global Phase 2 clinical trial of LB-P8, a novel therapeutic candidate for Primary Sclerosing Cholangitis (PSC), a rare and progressive liver disease with no approved treatments on November 5 (local time in the U.S.).
More news about: LISCure BioSciences
Nov 10, 2025, 07:00 ET Mallinckrodt Reports Third Quarter 2025 Financial Results
Mallinckrodt's historical "Specialty Brands" reportable segment and Endo's historical "Branded Pharmaceuticals" reportable segment, is focused on autoimmune and rare diseases across a range of therapeutic areas and includes Acthar Gel, XIAFLEX, and other branded therapeutics. The Generics
More news about: Keenova Therapeutics
Nov 10, 2025, 06:58 ET Biohaven Reports Third Quarter 2025 Financial Results and Recent Business Developments
clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of life-changing therapies to treat a broad range of rare and common diseases, today reported financial results for the third quarter ended September 30, 2025, and provided a review of recent accomplishments
More news about: Biohaven Ltd.